day 1 agenda

Thu , Jul 18, 2019

  • 08:00
  • Registrations

  • 09:00
  • Introduction & Inauguration

  • 09:15
  • Introduction to Organising committe members

  • 09:30 - 10:00
  • Keynote Talk-1

    Title: The impact of dementia on UK Black, Asian and minority ethnic communities
    David Truswell,
    Dementia Alliance for Culture and Ethnicity, UK

  • 10:00 - 10:30
  • Keynote talk-2

    Title: Functional cognitive disorder; new insights from cognitive data in fibromyalgia and chronic fatigue syndrome.
    Jeremy D Isaacs, St George’s University of London, UK

  • 10:30 - 11:00
  • Keynote talk-3

    Title: Omental Transposition to the Brain for Alzheimer’s Disease

    Harry S. Goldsmith, Emeritus professor, United States

  • 11:00
  • Refreshments

  • 11:10
  • Group Photo

  • 11:15 - 13:15
  • Scientific Session 1

    Title: The Utility Of Polygenic Risk Scores To Identify Individuals For Risk Of Cognitive Decline And Alzheimer’s Disease: New Opportunities For Clinical Trial Design
    Richard Pither, Cytox Ltd, united kingdom

    Title: Development of skin biomarkers as a rapid and least invasive diagnostic test for  Alzheimer’s and other neurodegenerative diseases
    Wenquan Zou, Case Western Reserve University School of Medicine, USA

    Title: Atypical presentation of Alzheimer’s disease – diagnosis and management
    Chuang-Kuo Wu, University of California - Irvine School of Medicine, United States

    Title: Synaptic dysfunction in dementia: JNK’s role
    Tiziana Borsello,  Università degli Studi di Milano, Italy

    Title: Structural effects of phosphorylation and the R406W mutation on tau
    Neal Zondlo,  University of Delaware, United States

    Title: Transcranial Magnetic Stimulation markers represent an innovative approach for the diagnosis of Prodromal Alzheimer Disease
    Alessandro Padovani, University of Brescia, Italy

  • 13:15 - 14:05
  • Lunch With Round table Discussions

  • 14:05 - 16:05
  • Scientific Session 2

    Title: Fenamates and Dementia: Gene therapy in a Pill
    Nasser H. Zawia, University of Rhode Island, USA

    Title: Putative diet and lifestyle risk factors in Dementia and cognitive impairment
    Douglas Wardell Wilson, Formerly Durham (UK) and Swansea (Wales), United Kingdom

    Title:Comparison of cholinergic status with quantitative EEG in healthy subjects and patients suspected of dementia.
    Rolf Ekedahl, NeuFydi, Sweden

    Title: Antidepressants, AKA1 and AKA5, increase  -amyloid deposition in APPswe/PSEN1dE9 transgenic mice
    Shing-Chuan Shen, Taipei Medical University, Taiwan

    Title: TREM2: Ramifications for hiPSC-Microglial functionality in AD
    Jennifer Pocock, Queen Square Institute of Neurology, United Kingdom

    Title: Neurotrophic factor a-1 gene mutation in AD patient leads to dementia and depression in mice
    Loh, Y Peng, National Institutes of Health, USA

  • 16:05
  • Refreshments

  • 16:15 - 17:15
  • Scientific Session 3

    Title: Cognitive Design based research on Dimentia
    Suraj Kumar,  National Institute of Design, India

    Title: The impact of virtual memory palaces on well-being with dementia
    Kasper Bormans, University of Leuven, Belgium

    Title: Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis
    Chin-Hsiao Tseng, National Taiwan University Hospital, Taiwan

  • 17:15
  • Note

    This is the tentative program and Program schedule is subjected to change with final allotment of speaker slots

day 2 agenda

Fri , Jul 19, 2019

  • 09:00
  • Registrations

  • 09:30 - 10:00
  • Keynote Talk-1

    Title: Development of iCrystal System for Rapid Crystallization of the Amyloid Precursor Protein 

    Jayfus Tucker Doswell,  The Juxtopia Group, USA

  • 10:00 - 10:30
  • Keynote talk-2

    Keynote Slot Available

     

  • 10:30 - 11:00
  • Keynote talk-3

    Keynote Slot Available

     

  • 11:00
  • Refreshments

  • 11:15 - 13:15
  • Scientific Sessions

    Title: Mechanistic approach to higher rate of AD among Arctic populations: activation of brain inflammatory pathways by elevated 2,3,7,8-TCDD body burdens.
    Ilya B. Tsyrlov, Xenotox. Inc, United States

    Title: Novel biologics reverse cognitive function deficits and amyloid plaques in Alzheimer’s disease animal models.
    Mourad Tayebi, Western Sydney University, Australia

    Title: DNA Polymerase as Therapeutic Intervention for Treating Patients with Multiple Sclerosis.          
    Sherif Salah Abdelaziz Hesen, Cairo University, Egypt

    Title: Silicic acid and beer consumption reverses the metal imbalance and the prooxidant status induced by aluminum nitrate in mouse brain
    Francisco José Sánchez Muniz, Complutense University, Spain

    Title: Role of the whole-exome sequencing analysis in diagnosis of clinically heterogenous families with ataxia.
    Marta Leńska-Mieciek, Centre of Postgraduate Medical Education, Warsaw, Poland

    Title: Therapeutic Benefits of the Camelid-Derived Antibodies in a Human Induced Pluripotent Stem Cells Derived from an Alzheimer’s Disease Patient
    Utpal Kumar Adhikari, Western Sydney University, Australia

  • 13:15 - 14:05
  • Lunch With Round table Discussions

  • 14:05 - 16:05
  • Scientific Session 2

    Title: Alzheimer’s disease causative viruses HSV-1 and CMV are highly susceptible targets for bHLH/PAS dioxin receptor-Arnt transcription pathway in glial cells.
    Ilya B. Tsyrlov, Xenotox. Inc, United States

    Title: The Dementia Care in Hospitals Program – A National Program to improve hospital care for patients with cognitive impairment.
    Mark Yates, Deakin University, Australia

    Title: APOE4 Polymorphism and The Pattern of  FTIR  Spectra  in Patients with  Alzheimer’s disease
    Sarawut Suksuphew, Suranaree University of Technology, Thailand

    Title: Crucial role of mitofilin and cyclophilin D interaction in post-ischemic GPER1-induced protection against ischemia-reperfusion injury.
    Jean C Bopassa, University of Texas Health Science San Antonio School of Medicine, USA

    Title: Regulatory Mechanism of miR-543-3p on GLT‑1 in a Mouse Model of Parkinson’s Disease
    Shaogang Qu, Shunde Hospital, Southern Medical University, China

    Title: Optical detection of Alzheimer’s disease in mice with single domain antibody fragments.
    Umma Habiba, Western Sydney University, Australia

  • 16:05
  • Refreshments

  • 16:15 - 17:15
  • Scientific Sessions-3

    Title: Interaction between Herpes Simplex Virus type 1 and APOE4 in the onset of Alzheimer’s disease in the Three-City prospective cohort study
    Linard Morgane, Inserm Bordeaux Population Health, France

    Title: Antidepressants, AKA1 and AKA5, induced intestinal microbial dysbiosis is associated with increased risk of Alzheimer’s disease
    Ming-Hsuan Liao, Taipei Medical University, Taiwan

    Spekaer slots are  available

  • 17:15
  • Panel Discussions

day 3 agenda

Sat , Jul 20, 2019

  • 09:00
  • Keynote Talk-1

  • 09:30
  • Keynote talk-2

  • 10:00
  • Scientific Sessions

  • 10:45
  • Refreshments

  • 11:00
  • Scientific Sessions

  • 13:15
  • Lunch

  • 14:00
  • Round table Discussions

  • 16:00
  • Refreshments

  • 16:15
  • Closing Ceremony

posters agenda

Tue , Oct 15, 2019

  • 14:00
  • Poster Presentations

    We will update soon.....

Tentative Program